Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Tax-Provision" stands at -6.56 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.
Sumitomo Dainippon Pharma Co Ltd's first quarter result of 0.726 Billion JPY for the item "Tax Provision" represents an increase of 108.22 percent compared to it's fourth quarter result of the company's last fiscal year.
Also, Sumitomo Dainippon Pharma Co Ltd's first quarter result of 0.726 Billion JPY for the item "Tax Provision" represents a decrease of -42.70 percent compared to it's first quarter result of last year.
Looking again at the trailing twelve months series (TTM), Sumitomo Dainippon Pharma Co Ltd's first quarter result of -6.56 Billion JPY for the item "Tax Provision" represents a decrease of -8.98 percent compared to it's fourth quarter result of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 8.16 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 8.16 Billion Japanese Yens.
The 3 year change is -60.30 Billion Japanese Yens.
The 5 year change is -30.80 Billion Japanese Yens.
The 10 year change is -24.13 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Tax Provision | 905,699,262,464.00 |
![]() | Johnson & Johnson - Tax Provision | 486,508,953,600.00 |
![]() | AbbVie Inc - Tax Provision | 399,570,305,024.00 |
![]() | Roche Holding AG - Tax Provision | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Tax Provision | 280,205,508,085.11 |